Drawing for EUROGENTEC

USPTO serial 79328123

EUROGENTEC

Reviewed by CopyMark Law Group

Reg. 7265178Status 700Registered
Filing date
Status date
Registration date
Jan 9, 2024
Examiner
BARRETT, LEAH N
Law office
TMEG LAW OFFICE 106

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EUROGENTEC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Burton S. Ehrlich

Burton S. Ehrlich Ladas & Parry LLP224 S. Michigan AvenueSuite 1600Chicago, IL 60604

Goods and services

ClassDescriptionStatusFirst use
001Chemical preparations and chemical reagents, all for scientific laboratory diagnosis, analysis and research, other than for medical and veterinary useACTIVE—
005Pharmaceutical and veterinary preparations, namely, vaccines, proteins, plasmids and conjugates; oligonucleotides kits and reagents, peptides kits and reagents, antibody production kits and reagents, molecular biology kits and reagents for medical use, namely, for use in disease research and treatments, qPCR, catalogue peptides and antibodies, assay kits; therapeutic (GMP) oligonucleotides, custom critical raw material (CRM) peptides, antibodies for medical or veterinary for use in disease research and treatments; in vitro transcribed RNA and recombinant proteins, plasmid DNA obtained by microbial fermentation, for preclinical, clinical and commercial use for pharmaceutical and veterinary preparations for use in disease research and treatments; disinfectants; chemical reagents for medical and veterinary purposesACTIVE—
042Research and development services on chemical products; services of analysis of chemical products; working on and evaluation of chemical synthesisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 2, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 29, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 10, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 10, 2024FIMPFINAL DISPOSITION PROCESSED—
Apr 9, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 9, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 9, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 24, 2023GPNXNOTIFICATION PROCESSED BY IB—
Oct 24, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 24, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 4, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 4, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 4, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 20, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 23, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 22, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 22, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
May 30, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 10, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 10, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Feb 22, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Feb 22, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 22, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 24, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 24, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 24, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 17, 2022RFNTREFUSAL PROCESSED BY IB—
Jul 26, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 26, 2022RFRRREFUSAL PROCESSED BY MPU—
Jul 23, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 22, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 15, 2022DOCKASSIGNED TO EXAMINER—
Dec 14, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 10, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 9, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance